Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
RAPP on Nasdaq
There are no Buy or Sell transactions made by ARCH Venture Partners XII, LLC since 24 Feb 2025
Holdings reported by ARCH Venture Partners XII, LLC for Rapport Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
3,728,738 |
$37,212,805 |
$9.98 |
10 Jun 2024 |
By ARCH Venture Fund XII, L.P. |
|
|
| Series A Preferred Stock |
0 |
|
|
10 Jun 2024 |
By ARCH Venture Fund XII, L.P. |
Common Stock |
|
| Series B Preferred Stock |
0 |
|
|
10 Jun 2024 |
By ARCH Venture Fund XII, L.P. |
Common Stock |
|
Transactions reported by ARCH Venture Partners XII, LLC for Rapport Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.